J. Vuillez, Biologie du FDG et des autres traceurs émetteurs de positons utilisés en cancérologie, pp.1-23, 1998.

F. Fkdk7, N(l,t'l;or~(~,le~ d e s Cerrt,re.s de L*i~tte C0ntr.e le C(~rrcer. Recominai~clations pour la pratique clinique. Standards, options et recommaildations 2003 pour l'utilisatioil de la toinogra, phie par éinission de positons au 1 8 ~ - ~ ~ ~ (TEP-FDG) cil caiic6rologic, 2003.

H. Visseaux, J. Vuillez, and J. G-i-r-a-u-d, Etude dosimétrique et optimisation de la radioprotection en

S. Waggoner, Cervical cancer, The Lancet, vol.361, issue.9376, pp.2217-2242, 2003.
DOI : 10.1016/S0140-6736(03)13778-6

W. Creasman, New Gynecologic Cancer Staging, Gynecologic Oncology, vol.58, issue.2, pp.157-158, 1995.
DOI : 10.1006/gyno.1995.1203

H. Keys, B. Bundy, F. Stehman, L. Muderspach, W. Chafe et al., Cisplatin, Radiation, and Adjuvant Hysterectomy Compared with Radiation and Adjuvant Hysterectomy for Bulky Stage IB Cervical Carcinoma, New England Journal of Medicine, vol.340, issue.15, pp.1154-61, 1999.
DOI : 10.1056/NEJM199904153401503

M. Morris, P. J. Eifel, J. Lu, P. Grigsby, C. Levenback et al., Pelvic Radiation with Concurrent Chemotherapy Compared with Pelvic and Para-Aortic Radiation for High-Risk Cervical Cancer, New England Journal of Medicine, vol.340, issue.15, pp.1137-1180, 1999.
DOI : 10.1056/NEJM199904153401501

W. Peters, P. Liu, R. Barrett, W. Gordon, R. Stock et al., Cisplatyl, 5-Fluorouracil plus radiation therapy are superior to radiation therapy us udj.uncttue t1~erup:y i r ~ I~igh-~"isk, eur1:y-stuge ~ w c i ~ ~ o r r ~ u of the ce7.,uis ufter radical hysterectomy and pelvic lymphadenectomy : report of a phase III intergroup study, 1999.

. N. Ro and . Dom, ized com,p~rison, of fluoro?~,racil p l ~ ~ s cisplatin ?~er.sus h,?jdroxyurea as an. adjunct to radiation therapy i n stages IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes : a Gynecologic oncology Groz~p and Southwest On

L. Wong, H. Ngan, A. Cheung, D. Cheng, and D. Choy, Chemoradiation and Adjuvant Chemotherapy in Cervical Cancer, Journal of Clinical Oncology, vol.17, issue.7
DOI : 10.1200/JCO.1999.17.7.2055

M. Berman, S. Bergen, and H. Salazar, Injluen,ce o,f hi~tological features an,d treatm.en.t on, th.e prognosis o,f patients ~ u i t h cervical cancer metastatic to pelvic lymph nodes, Gyiiecol. Oiicol, vol.39, issue.2, pp.127-131, 1990.

R. Lanciano and B. Corn, The role of surgical staging for cervical cancer, Seminars in Radiation Oncology, vol.4, issue.1, pp.46-51, 1994.
DOI : 10.1016/S1053-4296(05)80110-9

S. Bipat, A. Glas, and J. Van-der-velden, Computed tomography and magnetic resonance imaging i n staging of uterine ceniical carcin,oma : a s?jstem,ntic revieui, Gyilecol. Oilcol, vol.91, pp.59-66, 2003.

L. Subak, H. Hricak, C. Powell, L. Azizi, and J. Stern, Cervical carcinoma: Computed tomography and magnetic resonance imaging for preoperative staging, Obstetrics & Gynecology, vol.86, issue.1, pp.43-50, 1995.
DOI : 10.1016/0029-7844(95)00109-5

. Vergote-1, F. Amant, P. Berteloot, and M. Van-gramberen, Laparoscopic lower para-aortic staging lymphadenectomy i n stage IB2, II und III cervical cancer

T. Yen, L. See, and C. Lai, F-FDG uptake i n squamous ce11 carcinoma of tlze cervix is correlated with glucose transporter 1 expression, J . Nucl. Med, vol.45, pp.22-29, 2004.

Y. Sugawara, A. Eisbruch, S. Kosuda, B. Recker, P. Kison et al., Evnh~ntion of FDG P E T in pn1;ient.s luith cer?)

K. Narayan, R. Hicks, T. Jobling, D. Bernshaw, and A. Mckenzie, A comparison of MRI and PET scanning in surgically staged loco-regionally advanced cervical cancer: Potential impact on treatment, International Journal of Gynecological Cancer, vol.11, issue.4, pp.263-271, 2001.
DOI : 10.1046/j.1525-1438.2001.011004263.x

M. Reinhardt, C. Ehritt-braun, D. Vogelgesang, C. Ihling, S. Hogerle et al., Metastatic lymph nodes i n patients with cervical cancer : detection with M R Imagin, pp.776-782, 2001.

I. Kerr, M. Manji, J. Powe, S. Bakheet, A. Suhaibani et al., Positron Emission Tomography for the Evaluation of Metastases in Patients with Carcinoma of the Cervix: A Retrospective Review, Gynecologic Oncology, vol.81, issue.3, pp.477-480, 2001.
DOI : 10.1006/gyno.2001.6166

P. W. Grigsby, B. Siegel, and F. Dehdashti, Lymph Node Staging by Positron Emission Tomography in Patients With Carcinoma of the Cervix, Journal of Clinical Oncology, vol.19, issue.17, pp.3745-3749, 2001.
DOI : 10.1200/JCO.2001.19.17.3745

T. Belhocine, A. Thille, F. 'ridman, V. Albert, A. Seidel et al., Contribution of whole-body '*FDG P E T imaging i n the management of cervical cancer, Gyriecol. Oricol, vol.87, pp.90-97, 2002.

L. Yeh, Y. Hung, Y. Shen, C. Kao, C. Lin et al., Detecting para-aortic lymph nodal metastasis by positron emission tomography o,f 18F-fl11,orodeoxy,ql1~cose i n udvnnced cer~~ical can,cer uiith. n.egative magnetic resonance imaging findings, O~icol. Rep, vol.9, issue.6, pp.1259-92, 2002.
DOI : 10.3892/or.9.6.1289

W. Lin, Y. Hung, L. Yeh, C. Kao, R. Yen et al., U;sefidness of 18F-fluorotleox~jghrcose positron, em.is.sion tom,ograph,?j to detect para-aortic lymph nodal metastasis in advanced cervical cancer with negative computed tom,ography findings, Gyilecol. Oncol, vol.8, issue.9, pp.73-76, 2003.

T. Miller, E. Pinkus, F. Dehdashti, and P. Grigsby, Improved prognostic value of 1 8 ~ -~ ~ ~ P E T using a simple visual analysis of tumor characteristics i n patients with cervical cancer

C. Tsai, T. Chang, C. Lai, C. Tsai, K. Ng et al., Prelirrrinclry report of ,using FDG-PET tu detect eztr.upelvic lesioas i n cer.vicu1 cancer patients witlz enlarged pelvic lymph nodes on MRI/CT, Int. J.Radiat. Oncol. Biol. Pllys, issue.5, pp.58-1506, 2004.

T. Wong, E. Jones, and R. Coleman, Positron emission tomography with 2-deoxy-2-[18F]fluoro-D-glucose for evaluating local and distant disease in patients with cervical cancer, Molecular Imaging & Biology, vol.6, issue.1, pp.55-62, 2004.
DOI : 10.1016/j.mibio.2003.12.004

F. Stehman, B. Bundy, P. Disaia, H. Keys, J. Larson et al., Carcinoma of the cervix treated with radiation therapy I. A multi-variate analysis of prognostic variables in the gynecologic oncology group, Cancer, vol.33, issue.11, pp.277-85, 1991.
DOI : 10.1016/0360-3016(83)90060-3

L. Havrilesky, S. Kulasingam, D. Matchar, and E. Myers, FDG-PET for management of cervical and ovarian cancer, Gynecologic Oncology, vol.97, issue.1, pp.183-191, 2005.
DOI : 10.1016/j.ygyno.2004.12.007

. Diagr~os, is of recw.r,ent uterine ces~uicul cancer : corr~puted torr~opupl~y ,uer.s.us positron em,ission tomography. I(oreai1, J . Radiol, vol.l, issue.1, pp.51-55, 2000.

S. Ryu, M. Kim, S. Choi, C. Choi, and K. Lee, Detection of early recurrencewith 18F-FDG P E T in. patients with cervical can- cer

Y. Nakamoto, A. Eisbruch, and E. Achtyes, Prognostic Value of Positron Emission Tomography Using F-18-Fluorodeoxyglucose in Patients with Cervical Cancer Undergoing Radiotherapy, Gynecologic Oncology, vol.84, issue.2, pp.289-95, 2002.
DOI : 10.1006/gyno.2001.6504

S. , N. Ss,-c-h-e-n, T. C. Yen, R. S-h-e-n, Y. Y. Changlai et al., Value of whole body 18F-~~~or0-2-deoxyglucose positron emission tomography in th,e e?ia,l?~ation o,f recurren

W. C. H-u-n-g, Y. C. Lin, C. C. S-h-e-n, Y. Y. , and C. , Usefulness of FDG-PET to detect reccurent cervical cancer based on asymptomatically elevated tz~mor marker serum levels-a preliminary report, Cancer Iilvest, vol.22, issue.2, pp.180-84, 2004.

L. J. Havrilesky, T. Z. W-o-n-g, A. A. Secord, A. Berchuck, D. Clarke-pearson et al., The role of P E T scanning i n the detection of recurrent cervical cancer, Gy~iccol. Oricol, vol.90, pp.1136-189, 2003.

P. Grigsby and B. Siegel, D e h d a s h t i F, R a d e r J, Zoberi 1. Posttherapy 18F-~uorodeoxyglucose positron emission tomography i n carcinoma of the cervix : respon,se and outcome

C. H. Lai, K. G. See, L. C. , T. Z. , C. S. et al., Restaging of recurrent cervical carcinoma with dual-phase [18F]fluoro-2-deoxy-D-glucose positron emission tomography, Cancer, vol.19, issue.3, pp.544-552, 2004.
DOI : 10.1148/radiographics.19.suppl_1.g99oc19s103

T. Z. Yen, L. C. See, T. C. , K. G. , N. et al., q th,e priority 7l.çin.g 1RF-FDG P E T ,for recurren,t cenrical can,cer, J . Nucl. Med, issue.10, pp.45-1632, 2004.